You are here

  • Home
  • Archive
  • Volume 58, Issue 10
  • Globotriaosylsphingosine (lyso-Gb3) and analogues in plasma and urine of patients with Fabry disease and correlations with long-term treatment and genotypes in a nationwide female Danish cohort

Citation Tools

Article menu
Download PDFPDF
Biochemical genetics
Original research
Globotriaosylsphingosine (lyso-Gb3) and analogues in plasma and urine of patients with Fabry disease and correlations with long-term treatment and genotypes in a nationwide female Danish cohort

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Effraimidis G, Feldt-Rasmussen U, Rasmussen ÅK, et al
Globotriaosylsphingosine (lyso-Gb3) and analogues in plasma and urine of patients with Fabry disease and correlations with long-term treatment and genotypes in a nationwide female Danish cohort
Journal of Medical Genetics 2021;58:692-700.